Business Standard

Friday, December 20, 2024 | 06:09 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Steroids cut Covid-19 death rates, but it may not be good news for everyone

Based on the studies to date, hospitalized patients with Covid-19 pneumonia and requiring oxygen should be started on a low-dose course of steroids

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

Steroids have not been shown to benefit asymptomatic patients with Covid-19 or patients with mild disease

Bryan McVerry | The Conversation
New studies show that treating critically ill Covid-19 patients with inexpensive steroids can cut their risk of dying from the illness by a third. The results are so clear that the World Health Organization changed its advice on Sept. 2 and now strongly recommends corticosteroids as a first-line treatment for the sickest patients.
Steroids aren’t risk-free, however. They can have side effects, and they could do more harm than good in patients with milder cases of Covid-19.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in